Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,127 | 51,049 | 55,955 | 64,913 | 83,094 |
| Receivables | 356 | 355 | 355 | 1,609 | 1,732 |
| TOTAL | $47,272 | $53,739 | $59,131 | $71,736 | $90,070 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1,084 | 900 | 623 |
| Other Non-Current Assets | 0 | 7 | 2,267 | 2,444 | 2,613 |
| TOTAL | $N/A | $7 | $3,351 | $3,344 | $3,236 |
| Total Assets | $47,272 | $53,746 | $62,482 | $75,080 | $93,306 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 201 | 1,963 | 2,240 | 3,984 | 6,611 |
| Accrued Expenses | 1,951 | 2,867 | 6,101 | 8,232 | 7,762 |
| TOTAL | $2,152 | $4,834 | $9,149 | $13,002 | $15,138 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 1,554 | 1,730 | 1,903 |
| TOTAL | $N/A | $N/A | $1,554 | $1,730 | $1,903 |
| Total Liabilities | $2,152 | $4,834 | $10,703 | $14,732 | $17,041 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,975 | 73,975 | 73,975 | 73,739 | 73,705 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -878,461 | -874,442 | -871,362 | -862,956 | -849,632 |
| Other shareholders' equity | 331 | 331 | 333 | 337 | 338 |
| TOTAL | $45,120 | $48,912 | $51,779 | $60,348 | $76,265 |
| Total Liabilities And Equity | $47,272 | $53,746 | $62,482 | $75,080 | $93,306 |